sunset

A Patient’s Perspective

Immunotherapy is changing the way we perceive and treat cancer. Advances in science and technology…


Spotlight on Cancer Moonshot 2020

Cancer Moonshot 2020 plans to break down barriers and enable progress by enhancing data access,…


President Jimmy Carter to Undergo Immunotherapy Treatment

News of the United States’ 39th President Jimmy Carter and his recent diagnosis of advanced…


First Patient Enrolled in Combination Study with UCSF and Merck

On behalf of the OncoSec team, we’re thrilled to announce the first patient enrolled in the Phase…


Innovation Through An Academic Network: Part 3 The Future of Pharma

Looking ahead, our work is cut out for us in terms of R&D as many diseases and conditions are…


Innovation Through An Academic Network: Part 2 – Building New Channels to Advance Research

As we move into the Process Innovation era, new ways of developing more effective and safer…


Innovation Through An Academic Network: Part 1 - The Evolution of the Pharmaceutical Landscape

Today, the pharma landscape is increasingly multifaceted, but it’s taken us a while to reach this…


Cancer immunotherapy is providing options for patients who are out of options

Established in 2011 by Punit Dhillon, OncoSec Medical Inc. is a San Diego-based biotechnology…